% alzhub.org library filter
% Source: https://alzhub.org/research?author=Kester+MI
% 6 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{kester2015-26366630,
  author  = {Kester, M. I. and Teunissen, C. E. and Crimmins, D. L. and Herries, E. M. and Ladenson, J. H. and Scheltens, P. and van der Flier, W. M. and Morris, J. C. and others},
  title   = {{Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease}},
  journal = {JAMA neurology},
  year    = {2015},
  doi     = {10.1001/jamaneurol.2015.1867},
  pmid    = {26366630},
  url     = {https://doi.org/10.1001/jamaneurol.2015.1867}
}

@article{schoonenboom2012-22170879,
  author  = {Schoonenboom, N. S. and Reesink, F. E. and Verwey, N. A. and Kester, M. I. and Teunissen, C. E. and van de Ven, P. M. and Pijnenburg, Y. A. and Blankenstein, M. A. and others},
  title   = {{Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort}},
  journal = {Neurology},
  year    = {2012},
  doi     = {10.1212/wnl.0b013e31823ed0f0},
  pmid    = {22170879},
  url     = {https://doi.org/10.1212/wnl.0b013e31823ed0f0}
}

@article{kester2015-26383836,
  author  = {Kester, M. I. and Teunissen, C. E. and Sutphen, C. and Herries, E. M. and Ladenson, J. H. and Xiong, C. and Scheltens, P. and van der Flier, W. M. and others},
  title   = {{Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer's disease in a memory clinic cohort}},
  journal = {Alzheimer's research \& therapy},
  year    = {2015},
  doi     = {10.1186/s13195-015-0142-1},
  pmid    = {26383836},
  url     = {https://doi.org/10.1186/s13195-015-0142-1}
}

@article{kester2014-24818585,
  author  = {Kester, M. I. and Goos, J. D. and Teunissen, C. E. and Benedictus, M. R. and Bouwman, F. H. and Wattjes, M. P. and Barkhof, F. and Scheltens, P. and others},
  title   = {{Associations between cerebral small-vessel disease and Alzheimer disease pathology as measured by cerebrospinal fluid biomarkers}},
  journal = {JAMA neurology},
  year    = {2014},
  doi     = {10.1001/jamaneurol.2014.754},
  pmid    = {24818585},
  url     = {https://doi.org/10.1001/jamaneurol.2014.754}
}

@article{kester2009-19858456,
  author  = {Kester, M. I. and van der Vlies, A. E. and Blankenstein, M. A. and Pijnenburg, Y. A. and van Elk, E. J. and Scheltens, P. and van der Flier, W. M.},
  title   = {{CSF biomarkers predict rate of cognitive decline in Alzheimer disease}},
  journal = {Neurology},
  year    = {2009},
  doi     = {10.1212/wnl.0b013e3181bd8271},
  pmid    = {19858456},
  url     = {https://doi.org/10.1212/wnl.0b013e3181bd8271}
}

@article{goos2009-19762705,
  author  = {Goos, J. D. and Kester, M. I. and Barkhof, F. and Klein, M. and Blankenstein, M. A. and Scheltens, P. and van der Flier, W. M.},
  title   = {{Patients with Alzheimer disease with multiple microbleeds: relation with cerebrospinal fluid biomarkers and cognition}},
  journal = {Stroke},
  year    = {2009},
  doi     = {10.1161/strokeaha.109.558197},
  pmid    = {19762705},
  url     = {https://doi.org/10.1161/strokeaha.109.558197}
}